HIV Drugs: Trigger of Autoimmunity

Implicit, severe immune sensitive reactions to the anti-HIV drug abacavir materialize through an autoimmune procedure, resulting from the design of drug-induced immunizing agent that are attacked by the body's immune system as all HIV Drugs blocks protein synthesis and enzymes which cause alteration in and enzyme synthesis, autoimmune deformities accrue in HIV Patient and proteins. Many times foreign myalgia’s and arthralgia’s occur in about 5% of patients with HIV, sometimes in association with HIV seroconversion.  Many bone related diseases and HIV-associated arthralgia started progresses towards inflammatory joint disease and disorders because of HIV Treatment.

    Related Conference of HIV Drugs: Trigger of Autoimmunity

    December 14-15, 2017

    World Immunology Congress

    Dubai, UAE
    May 16-17, 2018

    World Congress on Allergy and Immunotherapy

    Osaka, Japan
    July 12-13, 2018

    5th International Conference on Parasitology

    Paris, France
    September 13-14, 2018

    Annual Congress on Immunology & Immunotechnology

    Zurich, Switzerland
    October 19-20, 2018

    10th World Congress and Expo on Immunology

    Baltimore, USA
    October 29-30, 2018

    6th International Conference on HIV/AIDS, STDs and STIs

    San Francisco, USA
    November 15-17, 2018

    Conference on Viral Infection and Immune Response

    Dubai, UAE
    November 26-27, 2018

    3rd International Conference on Autoimmunity

    Dublin, Ireland
    December 05-06-2018

    Conference on Biostatistics and Informatics

    Dubai, UAE
    December 13-14 , 2018

    Allergy and Clinical Immunology

    Abudhabi

    HIV Drugs: Trigger of Autoimmunity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in